Blogs about: Trastuzumab
Featured Blog
Roche to present at ESMO
Roche have announced that 100+ abstracts on Roche medicines will be presented at the upcoming European Society for Medical Oncology (ESMO) meeting. Key presentations include: * Data from AVAiL, conf… more →
Kinase News
Inflammatory breast cancer
JBBC wrote 2 months ago: The drug lapatinib could be used to treat aggressive inflammatory breast cancer suggest the findings … more →
Taxotere (and Herceptin) -- The Next Chapter
— 7 comments
RivkA (Coffee and Chemo) wrote 2 months ago: (cross posted from Coffee and Chemo. You can read the backstory here.) I thought it would be simpl … more →
Cancer vs. The Common Cold
— 1 comment
RivkA (Coffee and Chemo) wrote 6 months ago: (cross posted from Coffee and Chemo (here and here)) It occurred to me that having a cold might affe … more →
TDM1 (Trastuzumab-DM1) Immunoconjugate Drug Therapy Study Open at CORT
bmirtsching wrote 7 months ago: A phase III study of Trastuzumab-DM1 for treatment of relapsed her-2 positive metastatic breast canc … more →
ALLTO Study Evaluates the Role of Lapatinib (Tykerb) in Adjuvant Therapy of Her-2 Positive Breast Cancer
— 3 comments
bmirtsching wrote 8 months ago: CORT has opened the NCCTG N063D (BIG 2-06) study for adjuvant therapy of her-2 positive breast cance … more →
Treatment of Herceptin - how to survive the treatment with Herceptin
blogsforallcn wrote 8 months ago: The treatment of Herceptin is new a enough treatment for breast cancer. It in the beginning was a … more →
Roche to present at ESMO
crimsoncanary wrote 10 months ago: Roche have announced that 100+ abstracts on Roche medicines will be presented at the upcoming Europe … more →
Coadministration of CDK inhibitor seliciclib with EGFR inhibitors increases activity
crimsoncanary wrote 1 year ago: Studies published by Cyclacel on the coadministration of CDK inhibitor seliciclib with EGFR/HER2 inh … more →
Abraxane (nab-paclitaxel) with or without Herceptin in First-Line Treatment of Metastatic Breast Cancer: ION 04-012 Study Results from the ASCO 2008 Annual Meeting
bmirtsching wrote 1 year ago: The International Oncology Network (ION) Study 04-012 results were presented in a poster presentatio … more →
Trastuzumab-DM1 shows efficacy in metastatic breast cancer
crimsoncanary wrote 1 year ago: Data presented at ASCO show ImmunoGen/Genentechs Trastuzumab-DM1 immunoconjugate demonstrates effic … more →
Herceptin with Omnitarg effective in Breast cancer
crimsoncanary wrote 1 year ago: Phase II results presented at ASCO show Roche/Genentech’s show treatment with a combination of … more →
Phase III results show continued Herceptin helps women with advanced (metastatic) HER2-positive breast cancer live longer
crimsoncanary wrote 1 year ago: Herceptin (in combination with Xeloda) was found to prolong survival by nearly 3 months compared to … more →
Genentech clinical updates (full data to be presented at ASCO)
crimsoncanary wrote 1 year ago: Multiple updates on Avastin clinical progress to be presented as ASCO Updates on HER 2 program (Herc … more →
Is the era of Blockbuster pharmaceuticals over?
KHOI wrote 1 year ago: A blockbuster drug is define a drug that will make a $1 billion dollars or more for the company in a … more →
Lapatinib (Tykerb) for Treatment of Metastatic Breast Cancer
— 2 comments
bmirtsching wrote 1 year ago: According to results recently presented at the 2007 annual meeting of the American Society of Clinic … more →
When Traztuzumab Ceases To Be Just An Item for the Test...
— 5 comments
timelessboulevard wrote 2 years ago: When someone you know, most especially someone in the family, falls ill – diagnosed with … more →
Have your say. Start a blog.
See our free features →
An 
Medley
